Albendazole

Generic Name
Albendazole
Brand Names
Albenza
Drug Type
Small Molecule
Chemical Formula
C12H15N3O2S
CAS Number
54965-21-8
Unique Ingredient Identifier
F4216019LN
Background

A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)

Indication

For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

Associated Conditions
Hydatid disease of the Liver, Hydatid disease of the Lung, Hydatid disease of the Peritoneum, Neurocysticercosis
Associated Therapies
-

IVM Alone vs ALB + IVM Against Onchocerciasis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2017-08-03
Last Posted Date
2017-08-29
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
272
Registration Number
NCT03238131
Locations
🇬🇭

Committee on Human Research Publications and Ethics, Kumasi, Ashanti, Ghana

Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection

First Posted Date
2017-06-01
Last Posted Date
2024-07-25
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
39
Registration Number
NCT03172975
Locations
🇺🇸

George Washington University, Washington, District of Columbia, United States

Effect of Routine Deworming on Weight of Children

First Posted Date
2017-05-16
Last Posted Date
2017-07-13
Lead Sponsor
Dow University of Health Sciences
Target Recruit Count
300
Registration Number
NCT03155035
Locations
🇵🇰

Dow University of Health Sciences, Karachi, Sindh, Pakistan

Intestinal Microbiome Post-Azythromycin/Albendazole Treatment

First Posted Date
2017-01-26
Last Posted Date
2021-06-28
Lead Sponsor
University of California, San Francisco
Registration Number
NCT03032042
Locations
🇪🇹

The Carter Center Ethiopia, Addis Ababa, Ethiopia

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)

Phase 3
Active, not recruiting
Conditions
Interventions
First Posted Date
2017-01-09
Last Posted Date
2024-02-07
Lead Sponsor
University of Washington
Target Recruit Count
502363
Registration Number
NCT03014167
Locations
🇧🇯

Institut de Recherche pour le Développement, Comé, Benin

🇲🇼

London School of Hygiene and Tropical Medicine, Mangochi, Malawi

🇮🇳

Christian Medical College, Vellore, India

Lymphatic Filariasis (LF) in Ivory Coast

First Posted Date
2016-11-28
Last Posted Date
2022-04-21
Lead Sponsor
University Hospitals Cleveland Medical Center
Target Recruit Count
189
Registration Number
NCT02974049
Locations
🇨🇮

Cote d'Ivoire, Abidjan, Côte D'Ivoire

Design and Clinical Evaluation of a School Meal With Deworming Properties

First Posted Date
2016-03-31
Last Posted Date
2016-09-07
Lead Sponsor
Kenya Medical Research Institute
Target Recruit Count
326
Registration Number
NCT02725255

Impact of Periodontal Treatment on Serum Levels of Hepcidin and Hemoglobin

First Posted Date
2015-12-29
Last Posted Date
2015-12-29
Lead Sponsor
Federal University of Maranhao
Target Recruit Count
63
Registration Number
NCT02641210
© Copyright 2024. All Rights Reserved by MedPath